Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Net Income (2016 - 2025)

Macrogenics (MGNX) has disclosed Net Income for 14 consecutive years, with -$14.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 2.42% to -$14.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$77.7 million, a 9.67% decrease, with the full-year FY2025 number at -$74.6 million, down 11.39% from a year prior.
  • Net Income was -$14.1 million for Q4 2025 at Macrogenics, down from $16.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $54.2 million in Q3 2024 to a low of -$66.6 million in Q1 2022.
  • A 5-year average of -$32.1 million and a median of -$41.0 million in 2021 define the central range for Net Income.
  • Peak YoY movement for Net Income: crashed 2583.69% in 2021, then soared 252.64% in 2024.
  • Macrogenics' Net Income stood at -$58.2 million in 2021, then skyrocketed by 120.58% to $12.0 million in 2022, then tumbled by 511.87% to -$49.4 million in 2023, then surged by 70.67% to -$14.5 million in 2024, then increased by 2.42% to -$14.1 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Net Income are -$14.1 million (Q4 2025), $16.8 million (Q3 2025), and -$37.7 million (Q2 2025).